Moelis (MC) Q4 2025 earnings review
Record Revenues, But Expenses Eat the Upside
Moelis delivered record Q4 revenues of $488M (+11% YoY), validating the M&A recovery narrative. However, this top-line strength did not flow to the bottom line. Adjusted Net Income actually fell 1% YoY to $97.6M as compensation expenses surged 16%. While the firm is successfully capitalizing on deal flow—particularly in M&A and Capital Markets—the cost of talent retention and aggressive hiring is currently outpacing revenue growth, capping margin expansion.
🐂 Bull Case
Revenue growth is robust and broad-based. Full-year Adjusted revenues rose 28% to $1.54B. The firm is clearly participating in the dealmaking recovery, with M&A and Capital Markets citing higher average fees per transaction.
The balance sheet is pristine ($849M cash, no debt). Management authorized a new $300M share repurchase program (approx. 6% of market cap) and maintained the dividend, signaling confidence in future cash flow.
🐻 Bear Case
Expenses are growing faster than sales. While Q4 revenue grew 11%, compensation expense jumped 16% and non-comp expense rose 21%. The adjusted compensation ratio ticked up to 61.1% from 58.5% a year ago.
Capital Structure Advisory (restructuring) revenues declined. As the economy stabilizes and markets open, the counter-cyclical hedge provided by restructuring is fading, putting more pressure on M&A execution.
⚖️ Verdict: ⚪
Neutral. The revenue recovery is real, but the earnings power is being suppressed by high compensation costs. The new buyback authorization provides a floor, but investors need to see the 'record revenues' translate into record profits before getting aggressive.
Key Themes
Compensation Ratio Creep
Despite record revenues, Moelis lost operating leverage in Q4. The Adjusted Compensation Ratio rose to 61.1% (vs 58.5% in 24Q4). Management attributes this to 'higher bonus expense accrual' and increased headcount. If the firm cannot leverage expenses during a record revenue quarter, it raises questions about the structural profitability of the new hires.
M&A and Capital Markets Strength
M&A and Capital Markets are the clear engines of growth, offsetting weakness in restructuring. The firm cited 'increase in average fees earned per completed transaction' as the primary driver. This confirms the thesis that the deal size and complexity are improving, not just volume.
Capital Structure Advisory Fade
Reversing. After a record run in 2024, the restructuring business is decelerating. The release explicitly notes a 'decline in Capital Structure Advisory' revenue. This removes a key diversification pillar that protected the firm during the M&A downturn.
Aggressive Headcount Expansion
Accelerating. Moelis ended the year with 178 Managing Directors (up from ~169 at the start of the year). They promoted 13 MDs in early 2026 and have more external hires joining (including in Private Credit Secondaries). This signals management is betting heavily on a multi-year upcycle.
Private Credit Secondaries Entry
The firm explicitly mentioned a new Managing Director joining the 'Private Capital Advisory team' focused on private credit secondaries. This targets a niche but rapidly growing market as LPs seek liquidity in private credit portfolios.
Non-Compensation Inflation
Adjusted non-compensation expenses rose 21% YoY in Q4. Drivers include deal-related travel, client conferences, and occupancy. This confirms a return to 'normal' business activity levels but adds another layer of drag to margins.
Other KPIs
Decelerating vs 24Q4 (31.4%). While 28.6% is a healthy absolute margin and a massive improvement over the YTD average (21.5%), it is lower than the comparable quarter last year despite higher revenue. This reinforces the negative operating leverage theme.
Stable/Strong. Cash balance represents nearly 20% of the firm's market cap. With zero debt and no goodwill, this provides immense flexibility for the newly authorized $300M buyback and continued dividend payments.
Accelerating. Up 64% from $1.82 in FY24. The full-year recovery story remains intact, even if Q4 showed some cost friction. Note: FY25 includes a ~$0.28 tax benefit related to share-based awards settlement.
Guidance
Management states they are 'well positioned to drive growth' entering 2026, citing the 'strongest coverage platform in our history.' No specific numeric guidance was provided, consistent with industry practice.
Accelerating. The board approved a new $300M authorization. For context, they repurchased only $61M in the entirety of FY25. This suggests a significantly more aggressive capital return posture for FY26.
Key Questions
Comp Ratio Stickiness
With Q4 revenue hitting a record $488M, why did the compensation ratio expand to 61% from 58.5% last year? At what revenue level can we expect to see leverage return to the mid-50s?
Capital Structure Runway
You noted a decline in Capital Structure Advisory. Is this a structural reset to pre-2024 levels, or do you see a floor forming in restructuring activity given the maturity walls in commercial real estate and private credit?
Non-Comp Expense Cadence
Non-comp expenses grew 21% YoY. Is this the new run-rate given the return to travel and conferences, or was Q4 impacted by one-time items?